Antiplatelet Agents Current Events | Antiplatelet Agents News
|
| Page
1 of
13 |
247 Results |
|
|
|
Sort By:
Page Views | Date |
Bleeding during endoscopy: Do anti-inflammatories play a role?
Does an aspirin-a-day increase the risk of bleeding during invasive diagnostic procedure? This is an important concern for many patients who take these and other antiplatelet agents in an effort to reduce heart attacks or strokes. view more (2007-03-16)
Aspirin protects patients at high risk of heart attack or stroke
Aspirin (or another antiplatelet drug) protects patients at high risk of serious vascular events, such as heart attack or stroke, and should be considered routinely for all such patients, concludes a study in this week's BMJ. view more (2002-01-09)
Safety of antithrombotic treatment in acute coronary syndromes
The management of acute coronary syndromes (with or without ST segment elevation) requires the use of anticoagulants, antiplatelet agents (aspirin, clopidogrel and/or glycoprotein (GP) IIb/IIIa inhibitors), beta-blockers, thrombolytics in some cases, and revascularization / reperfusion. view more (2008-09-03)
Best use of drug-eluting stents
Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction. view more (2008-09-02)
Early reports of thrombosis after insertion of drug-eluting stent (pp 1466, 1519)
Authors of a research letter in this week's issue of THE LANCET highlight how the use of drug-eluting stents (DES) may carry a risk of subsequent thrombosis if stenting is accompanied by a withdrawal of antiplatelet therapy. view more (2004-10-20)
Triple antiplatelet therapy appears superior to dual antiplatelet therapy
Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention (PCI)... view more... (2008-10-14)
Genetic variation associated with poorer response, cardiovascular outcomes with use of clopidogrel
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event... view more... (2009-08-26)
Study Finds Half of Patients Undergoing Cerebrovascular Stent Placement Respond Poorly to the Antiplatelet Drug Clopidogrel (Plavix)
A study by researchers at Rush University Medical Center, published in the February issue of the American Journal of Neuroradiology, finds that half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel. Clopidogrel (Plavix) and aspirin are medications routinely prescribed for 1-3 months following... view more... (2008-02-06)
Some antidepressants associated with gastrointestinal bleeding
A class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) appear to be associated with bleeding in the upper gastrointestinal tract. view more (2008-07-08)
Patients who receive drug-eluting stents should continue antiplatelet medications
Patients who have had drug-eluting stents inserted to prop open blocked coronary arteries should continue to take medications to reduce the risk of blood clots for at least one year after the stent is inserted, a new scientific advisory recommends. view more (2007-01-17)
Newer contrast agents safe for children
Allergic-like reactions to newer iodine-containing contrast agents (nonionic contrast media), are rare in children according to a recent study conducted by researchers from the University of Michigan Medical Center and C.S. Mott Children's Hospital both in Ann Arbor. view more (2007-06-08)
For some, aspirin doesn't increase risk of recurring hemorrhagic stroke
Aspirin is typically prescribed for people at risk of having an ischemic stroke to prevent blood clots. Because aspirin may cause bleeding, it is typically avoided in people who have had a hemorrhagic stroke, also called intracerebral hemorrhage. view more (2006-01-24)
Atherothrombosis patients world-wide often have undertreated, undercontrolled risk factors
A large international study demonstrates that patients world-wide with atherothrombosis (coronary artery disease, cerebrovascular disease, peripheral arterial disease) often have cardiovascular risk factors such as obesity and hypertension that are undertreated and undercontrolled. view more (2006-01-11)
Over 40,000 Lives Lost Worldwide Every Year
The 'humble' aspirin, which has been known for at least a decade to prevent heart attacks and strokes in thousands of people at high risk of cardiovascular disease, is still massively underused, according to new research published today (Fri Jan 11) in the British Medical Journal. Previous studies show that aspirin (and other antiplatelet drugs)... view more... (2002-01-09)
Even at High Doses, Gadolinium-Based Contrast Agents Cannot by Themselves Cause Patients to Develop Nephrogenic Systemic Fibrosis
Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems. view more (2009-07-01)
Despite ongoing safety concerns, study finds adverse reactions from contrast agents rarely occur
Iodinated and Gadolinium based contrast agents, frequently used during computed tomography (CT) and MRI scans to aid in the imaging process, are associated with a very low rate of adverse effects, according to a large cohort study published in the October issue of the American Journal of Roentgenology (AJR). view more (2009-09-21)
A new therapeutic option for human hepatocyte cancer
p53-impaired tumors may be particularly suitable to parvovirus H-1-induced therapy. Although the p53 deficiency in tumors may induce resistance to chemotherapeutic agents, this will not affect the tumor cell susceptibility to H-1 PV-induced oncolytic infections. view more (2008-09-24)
'Information agents' for faster, better emergency response
'Information agents' have been developed that could prove invaluable in decision-making and directing the actions of the emergency services in the immediate aftermath of natural disasters or terrorist attacks. view more (2009-03-04)
Researcher working on destruction of chemical weapons
America's war on terror includes fighting the dark side of deadly chemical agents, and Texas A&M University chemist Dr. Frank Raushel is helping with the fight by developing an enzyme that might neutralize one such chemical agent, the organophosphates. view more (2008-09-25)
Can Computers Argue?
The answer is yes, and not only that: they can also evaluate what will be the most successful strategy for conflict resolution, including re-formulating their action, or evading confrontation. Argument is used by computer agents only as the last resort. The effectiveness of argumentation-based negotiation (ABN) for computer agents operating in... view more... (2004-07-05)
|
|
| Page
1 of
13 |
247 Results |
|
|
|
Sort By:
Page Views | Date |
|
